Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial.
Braik N, Guedeney P, Behnes M, Desch S, Barthélémy O, Sandri M, de Waha-Thiele S, Fuernau G, Rouanet S, Hauguel-Moreau M, Zeitouni M, Overtchouk P, Ouarrak T, Schneider S, Zeymer U, Thiele H, Montalescot G, Akin I. Braik N, et al. Among authors: zeymer u. Am Heart J. 2021 Feb;232:185-193. doi: 10.1016/j.ahj.2020.11.009. Epub 2020 Nov 27. Am Heart J. 2021. PMID: 33253678 Clinical Trial.
Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).
Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Zeymer U, et al. Eur Heart J. 2004 Feb;25(4):322-8. doi: 10.1016/j.ehj.2003.12.008. Eur Heart J. 2004. PMID: 14984921
[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R, Hamm CW, Zeymer U, Schneider S, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Schöbel WA, Sabin G, Senges J; deutsche Cyper-Register. Zahn R, et al. Among authors: zeymer u. Herz. 2004 Mar;29(2):181-6. doi: 10.1007/s00059-004-2560-x. Herz. 2004. PMID: 15057439 German.
Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial.
Zeymer U, Zahn R, Schiele R, Jansen W, Girth E, Gitt A, Seidl K, Schröder R, Schneider S, Senges J. Zeymer U, et al. Eur Heart J. 2005 Oct;26(19):1971-7. doi: 10.1093/eurheartj/ehi293. Epub 2005 Apr 27. Eur Heart J. 2005. PMID: 15857851 Clinical Trial.
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry).
Zahn R, Hamm CW, Schneider S, Zeymer U, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Senges J; German Cypher Stent Registry. Zahn R, et al. Among authors: zeymer u. Am J Cardiol. 2005 Jun 1;95(11):1302-8. doi: 10.1016/j.amjcard.2005.01.072. Am J Cardiol. 2005. PMID: 15904633
Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.
Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Senges J; German Cypher Stent Registry. Zahn R, et al. Among authors: zeymer u. Am Heart J. 2006 Dec;152(6):1146-52. doi: 10.1016/j.ahj.2006.07.011. Am Heart J. 2006. PMID: 17161068
615 results